Showing results (291-300 of 384) with videos related to

Sort By:
Pageof 39
Urology|June 18, 2003
Identification and preliminary clinical evaluation of a 50.8-kDa serum marker for prostate cancerJohn J Hlavaty, Alan W Partin, Matthew J Shue, et al.
Prostate Cancer and Prostatic Diseases|August 22, 2020
A novel method for detection of exfoliated prostate cancer cells in urine by RNA in situ hybridizationJillian N Eskra, Daniel Rabizadeh, Leslie Mangold, et al.
The Journal of Urology|April 29, 2014
Obesity and long-term survival after radical prostatectomyHeather J Chalfin, Seung Bae Lee, Byong Chang Jeong, et al.
Urology|December 15, 2004
Clinical utility of proPSA and "benign" PSA when percent free PSA is less than 15%Masood A Khan, Lori J Sokoll, Daniel W Chan, et al.
Urology Practice|June 14, 2023
Quality Improvement Summit 2016: Shared Decision Making and Prostate Cancer ScreeningDanil V Makarov, Margaret Holmes-Rovner, David R Rovner, et al.
Cancer Research|January 2, 2009
Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancerRong Hu, Thomas A Dunn, Shuanzeng Wei, et al.
Proteomics|November 5, 2003
Microarrays of tumor cell derived proteins uncover a distinct pattern of prostate cancer serum immunoreactivityKerri Bouwman, Ji Qiu, Heping Zhou, et al.
Transfusion|March 8, 2014
Allogeneic versus autologous blood transfusion and survival after radical prostatectomyHeather J Chalfin, Steven M Frank, Zhaoyong Feng, et al.
The Journal of Urology|January 15, 2013
The impact of prostate volume, number of biopsy cores and American Urological Association symptom score on the sensitivity of cancer detection using the Prostate Cancer Prevention Trial risk calculatorDonna P Ankerst, Cathee Till, Andreas Boeck, et al.
Cancer|February 6, 2003
Quantitative biopsy pathology for the prediction of pathologically organ-confined prostate carcinoma: a multiinstitutional validation studyAlexander Haese, Manisha Chaudhari, M Craig Miller, et al.
Pageof 39